Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Kabra Drugs Ltd has informed BSE that it published the extract of its audited financial results for the quarter and year ended March 31, 2026, in two newspapers. The results appeared in Free Press (English) and Navbharat (Hindi). This disclosure is made under Regulation 47 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015, which mandates newspaper publication of financial results. The notice was signed by Managing Director Nanjappan Aravind (DIN: 01895602) on June 3, 2026. The BSE scrip code is 524322. No actual financial figures or results data are included in this filing.
This is a routine regulatory compliance filing confirming newspaper publication of already-filed audited results. No new financial information, business update, or material event is disclosed, so there is no direct impact on shareholders or the stock price.